## Abstract Patients with Parkinson's disease (PD) often have cognitive deficits from the time of diagnosis. Except in patients with dementia, the impact of cognitive symptoms on daily function is not well documented. This study had two objectives: (1) to determine the functional significance of co
The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia
β Scribed by Lee, Wei-Ju; Tsai, Chia-Fen; Gauthier, Serge; Wang, Shuu-Jiun; Fuh, Jong-Ling
- Book ID
- 111987638
- Publisher
- Cambridge University Press
- Year
- 2012
- Tongue
- English
- Weight
- 566 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1041-6102
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The objective of this study is to compare the occurrence of dementia among Parkinson's disease (PD) patients treated with amantadine (AM group) with those never exposed to it (NoAM group). PD dementia shares neuroanatomical and biochemical similarities with Alzheimer's disease (AD). Mem
## Abstract ## Objective Cognitive impairment is an important determinant for functional impairment in Alzheimer's disease. The role of nonβcognitive symptom is uncertain. The objective of this study was to investigate the role of nonβcognitive symptoms as predictive factors for functional outcome
## Abstract Valid tools are needed to assess depression across the spectrum of cognitive impairment in Parkinson's disease (PD). The validity of the Cornell scale for depression in dementia (CSDD) was tested in a PD sample with a range of cognitive impairment. Psychiatric diagnoses were established